3-n-butylphthalide has been researched along with Cerebral Arteriosclerosis in 1 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chen, D; Li, B; Li, W; Shi, J; Wang, K; Yang, F; Yin, Y; Zhao, F | 1 |
1 trial(s) available for 3-n-butylphthalide and Cerebral Arteriosclerosis
| Article | Year |
|---|---|
DL-3-n-butylphthalide improves cerebral hypoperfusion in patients with large cerebral atherosclerotic stenosis: a single-center, randomized, double-blind, placebo-controlled study.
Topics: Benzofurans; Double-Blind Method; Humans; Intracranial Arteriosclerosis; Neuroprotective Agents | 2020 |